2025-05112NoticeWallet

Blood Stem Cell Council Gets Two More Years

Published Date: 3/26/2025

Notice

Summary

The Advisory Council on Blood Stem Cell Transplantation (ACBSCT) got its official green light to keep working until February 19, 2027. This council helps the government improve bone marrow and cord blood transplants by giving expert advice on new science and therapies. Patients needing these life-saving transplants and the programs supporting them will benefit from the council’s continued guidance.

Analyzed Economic Effects

2 provisions identified: 2 benefits, 0 costs, 0 mixed.

Advisory council renewed through 2027

You will continue to have an expert advisory council (the ACBSCT) providing guidance on bone marrow and cord blood transplant programs because the council's charter was renewed effective February 19, 2025 and authorizes operation until February 19, 2027.

Possible review and inclusion of new stem cell therapies

The council may review the state of the science using adult stem cells and birthing tissues to develop new therapies and consider including such new types of therapies in the C.W. Bill Young Cell Transplantation Program.

Personalized for You

How does this regulation affect your finances?

Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Key Dates

Effective Date
Published Date
2/19/2025
3/26/2025

Department and Agencies

Department
Independent Agency
Agency
Health and Human Services Department
Health Resources and Services Administration
Source: View HTML

Related Federal Register Documents

Previous / Next Documents

Back to Federal Register